GAL and ovarian carcinoma: Other galectin inhibiting small molecules include 6DBF7, a dibenzofuran (DBF)-based peptidomimetic of the Gal-1, which has been shown to block tumor angiogenesis and tumor growth in melanoma, lung, and ovarian cancer mouse models [170].